Moreover, using the cancer cell line encyclopedia (CCLE) database, we found that the R273 signature is significantly upregulated in CRC cell lines harboring R273 mutations, compared to CRC lines carrying protein-truncating TP53 mutations (Fig. 4a). This evidence concerns the gene TP53 and cancer.